Cite
HARVARD Citation
Batty, N. et al. (2014). Decitabine is more cost effective than cytarabine and daunorubicin in elderly acute myeloid leukemia patients. Journal of cancer research & therapy. 2 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Batty, N. et al. (2014). Decitabine is more cost effective than cytarabine and daunorubicin in elderly acute myeloid leukemia patients. Journal of cancer research & therapy. 2 (4), p. . [Online].